Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-25
1994-03-08
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514210, 514255, 514318, 514326, 514332, 514333, 514336, 514340, 514341, 514342, 514343, 514374, 514376, 514381, 514383, 514397, 514401, 514422, 540 1, 540544, 544358, 544359, 544360, 544366, 544367, 544372, 546 22, 546193, 546201, 546208, 546209, 546210, 546212, 546213, 546216, 546218, 546221, 546222, 546225, 546232, 546255, 546256, 546268, 546275, 546276, 546278, 546281, 548112, 548237, 548238, 548253, 548254, 5482666, 5483147, 5483151, 5483167, 564 47, 564 84, 564 92, A61K 31445, C07D26722, C07D2
Patent
active
052927563
ABSTRACT:
A series of non-peptide derivatives of the formula ##STR1## that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
REFERENCES:
patent: 4098889 (1978-07-01), Dunbar
patent: 4122255 (1992-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4622331 (1986-11-01), Jozic
patent: 4977165 (1990-12-01), Oinuma
patent: 5030654 (1991-07-01), Barnish
patent: 5064814 (1991-11-01), Klein et al.
Ruoslahti et al "New Perspectives in Cell Adhesion" Science 238 491-497 (1987).
Duggan Mark E.
Egbertson Melissa S.
Halczenko Wasyl
Hartman George D.
Chang Celia
Ivy C. Warren
Matukaitis Paul D.
Merck & Co. , Inc.
Parr Richard S.
LandOfFree
Novel sulfonamide fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel sulfonamide fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel sulfonamide fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-153607